Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Aspberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
JAMA Ophthalmology|November 23, 2022
Estimating the Length of the Preclinical Detectable Phase for Open-Angle GlaucomaJohan Aspberg, Anders Heijl, Boel Bengtsson
BMC Ophthalmology|November 15, 2011
The effect of different criteria on the number of patients blind from open-angle glaucomaAnders Heijl, Johan Aspberg, Boel Bengtsson
American Journal of Ophthalmology|April 6, 2021
Screening for Open-Angle Glaucoma and Its Effect on BlindnessJohan Aspberg, Anders Heijl, Boel Bengtsson
American Journal of Ophthalmology|March 16, 2025
Corrigendum to "The Glaucoma Intensive Treatment Study (GITS): A Randomized Controlled Trial Comparing Intensive and Standard Treatment on 5 Years Visual Field Development" [Am J Ophthalmol 2024;266:274-288]Boel Bengtsson, Anders Heijl, Johan Aspberg, et al.
Acta Ophthalmologica|July 30, 2021
The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trialBoel Bengtsson, Christina Lindén, Anders Heijl, et al.
Acta Ophthalmologica|September 23, 2018
Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment StudyChristina Lindén, Anders Heijl, Gauti Jóhannesson, et al.
Acta Ophthalmologica|September 2, 2018
The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline dataBoel Bengtsson, Anders Heijl, Gauti Johannesson, et al.
Journal of Glaucoma|August 17, 2018
Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for GlaucomaJohan Aspberg, Anders Heijl, Gauti Jóhannesson, et al.
American Journal of Ophthalmology|June 23, 2024
The Glaucoma Intensive Treatment Study (GITS): A Randomized Controlled Trial Comparing Intensive and Standard Treatment on 5 Years Visual Field DevelopmentBoel Bengtsson, Anders Heijl, Johan Aspberg, et al.
Acta Ophthalmologica|June 24, 2022
Threat to fixation and vision-related quality of life in early open-angle glaucoma - results from the Glaucoma Intensive Treatment StudyDorothea Peters, Anders Heijl, Sabina Andersson-Geimer, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
JAMA Ophthalmology|November 23, 2022
Estimating the Length of the Preclinical Detectable Phase for Open-Angle GlaucomaJohan Aspberg, Anders Heijl, Boel Bengtsson
BMC Ophthalmology|November 15, 2011
The effect of different criteria on the number of patients blind from open-angle glaucomaAnders Heijl, Johan Aspberg, Boel Bengtsson
American Journal of Ophthalmology|April 6, 2021
Screening for Open-Angle Glaucoma and Its Effect on BlindnessJohan Aspberg, Anders Heijl, Boel Bengtsson
American Journal of Ophthalmology|March 16, 2025
Corrigendum to "The Glaucoma Intensive Treatment Study (GITS): A Randomized Controlled Trial Comparing Intensive and Standard Treatment on 5 Years Visual Field Development" [Am J Ophthalmol 2024;266:274-288]Boel Bengtsson, Anders Heijl, Johan Aspberg, et al.
Acta Ophthalmologica|July 30, 2021
The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trialBoel Bengtsson, Christina Lindén, Anders Heijl, et al.
Acta Ophthalmologica|September 23, 2018
Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment StudyChristina Lindén, Anders Heijl, Gauti Jóhannesson, et al.
Acta Ophthalmologica|September 2, 2018
The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline dataBoel Bengtsson, Anders Heijl, Gauti Johannesson, et al.
Journal of Glaucoma|August 17, 2018
Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for GlaucomaJohan Aspberg, Anders Heijl, Gauti Jóhannesson, et al.
American Journal of Ophthalmology|June 23, 2024
The Glaucoma Intensive Treatment Study (GITS): A Randomized Controlled Trial Comparing Intensive and Standard Treatment on 5 Years Visual Field DevelopmentBoel Bengtsson, Anders Heijl, Johan Aspberg, et al.
Acta Ophthalmologica|June 24, 2022
Threat to fixation and vision-related quality of life in early open-angle glaucoma - results from the Glaucoma Intensive Treatment StudyDorothea Peters, Anders Heijl, Sabina Andersson-Geimer, et al.
Pageof 2